Johnson & Johnson

1. NJ Jury Finds For AstraZeneca In 1st Seroquel Verdict

Thursday, Mar 18, 2010

A jury in New Jersey state court found in favor of AstraZeneca Pharmaceuticals LP on Thursday, handing down the first verdict to come out of more than 10,000 cases over claims that Seroquel causes diabetes.

2. Fujifilm, UPS Face False Patent Marking Qui Tam Suits

Thursday, Mar 11, 2010

People Protecting Patents LLC hauled Fujifilm Holdings Corp. into court Thursday over allegations that the company marks its disposable cameras with expired patents, following a similar suit the whistleblower filed against United Parcel Service Inc. the day before.

3. $1M Trimmed From $4.8M Award Over Remicade Ads

Tuesday, Mar 09, 2010

A Texas appeals court has stripped $1 million from a $4.8 million award to a couple who claimed Johnson & Johnson Inc. subsidiary Centocor Inc.'s advertising misled them into thinking its Remicade drug was safe.

4. Pfizer Spits Out Class Cert. In Listerine Ad Suit

Wednesday, Mar 03, 2010

Reconsidering a ruling in light of new case law, a California appeals court has again overturned class certification in a suit alleging Pfizer Inc. misled consumers about the benefits of using Listerine.

5. Boston Scientific Cross-Appeals Stent Patent Ruling

Wednesday, Mar 03, 2010

Weeks after Johnson & Johnson Inc. appealed a federal court's ruling that four of its patents for drug-eluting stents are invalid, Boston Scientific Corp. has notified the court that it will also appeal parts of that case.

6. Ortho, Braun Marked Drugs With Expired Patents: Suits

Tuesday, Mar 02, 2010

A retired Philadelphia doctor has sued Ortho-McNeil-Janssen Pharmaceuticals Inc. and B. Braun Medical Inc. alleging they falsely marked medical supplies and drugs — including schizophrenia treatment Risperdone — as patented.

7. Wyeth, Apotex Vie For Quick Win In Effexor Patent Suit

Monday, Mar 01, 2010

Pharmaceutical giant Wyeth Inc. and generic-drug maker Apotex Inc. have each asked a federal judge to rule in their favor in a patent infringement suit brought by Wyeth over Apotex's planned generic version of popular antidepressant Effexor.

8. J&J Unit Recalls 14,000 Blood Glucose Test Strips

Friday, Feb 26, 2010

Johnson & Johnson unit LifeScan Inc. has recalled eight lots of its OneTouch SureStep blood glucose test strips — used by diabetics to monitor their glucose level — because the strips can produce falsely low readings.

9. Cordis Wins $4.7M In Fees In MarcTec Stent Patent Suit

Thursday, Feb 25, 2010

A federal judge has awarded Johnson & Johnson subsidiary Cordis Corp. about $4.7 million in attorneys' costs and expert fees incurred during the defense of medical device maker MarcTec LLC's infringement suit over stent patents.

10. US Widens Probe Into Eli Lilly's FCPA Compliance

Tuesday, Feb 23, 2010

The U.S. Department of Justice and the U.S. Securities and Exchange Commission have widened an investigation into Eli Lilly & Co. subsidiaries' compliance with a federal law that prohibits bribery of foreign officials, the company has disclosed.

11. High Court Seeks SG Input On Procrit Whisteblower Suit

Monday, Feb 22, 2010

The U.S. Supreme Court has asked that the solicitor general weigh in on whether a whistleblower can bring kickback claims against Ortho Biotech Products LP after the alleged scheme was already revealed in a multidistrict litigation.

12. Hologic, J&J Unit Strike $12.5M Deal In Biopsy IP War

Friday, Feb 19, 2010

Medical device company Hologic Inc. has agreed to pay $12.5 million to end a long-running patent battle with Johnson & Johnson unit Ethicon Endo-Surgery Inc., putting to rest three lawsuits over biopsy products.

13. Bayer Sues Lupin Over Generic Cipro

Friday, Feb 19, 2010

Bayer Schering Pharma AG has hit Indian drugmaker Lupin Ltd. with a patent infringement suit over plans to introduce generic versions of Cipro, the branded form of anti-microbial drug ciprofloxacin.

14. J&J Can't Revive Claims Against Abbott, Boston Sci

Thursday, Feb 18, 2010

A federal judge has ruled that Johnson & Johnson cannot amend its complaint to resurrect its breach of contract and anti-competitive conduct claims against Abbott Laboratories and Boston Scientific Corp. in a $5.5 billion suit over its failed bid to acquire Guidant Corp.

15. Lupin Aims To Invalidate Ortho Birth Control Patent

Thursday, Feb 18, 2010

Responding to a patent infringement suit brought by Ortho-McNeil-Janssen Pharmaceuticals Inc., India-based generic-drug maker Lupin Pharmaceuticals Inc. has asked a federal judge to invalidate Ortho's patent for contraceptive Tri-Cyclen Lo.

16. J&J Appeals Invalidity Ruling For Stent Patents

Thursday, Feb 18, 2010

Johnson & Johnson Inc. has appealed a federal court's ruling in favor of plaintiff Boston Scientific Corp. that four of J&J's patents for drug-eluting stents are invalid.

17. J&J Unit Escapes Artificial Disc Negligence Claims

Tuesday, Feb 16, 2010

A federal appeals court on Tuesday upheld summary judgment for DePuy Spine Inc. on a customer's claims that the company negligently manufactured a spinal disc replacement product.

18. Alza, Sandoz Pain Patch Case Stays In Federal Court

Wednesday, Feb 10, 2010

A widower's case against Alza Corp. and Sandoz Inc. over an allegedly defective fentanyl pain patch will stay in federal court after a judge dismissed DVS Pharmacy Inc. from the suit, giving the court diversity jurisdiction.

19. Senate Confirms Greenaway For 3rd Circ. Seat

Tuesday, Feb 09, 2010

The U.S. Senate voted unanimously Tuesday to confirm U.S. District Judge Joseph A. Greenaway Jr. to fill a vacancy on the U.S. Court of Appeals for the Third Circuit.

20. Akin Gump Adds 3 Top IP Litigators From Woodcock

Tuesday, Feb 09, 2010

Woodcock Washburn LLP litigation practice leader Dianne Elderkin, who helped secure the largest patent litigation verdict in U.S. history, is leaving the firm with two fellow partners to join Akin Gump Strauss Hauer & Feld LLP’s Philadelphia office.